That was Cephalon being taken over by Teva and Teva who'd bought Cephalon because of it's partnership with MSB as one of the reasons, then messed up with it's backing of DRUG clinical trials.
THAT has nothing to do with MSB. Lucky we got all our IP back with no charge from that episode. It was a set-back but only due to bone-headed number crunchers taking over at Teva.
Analysis of the EAP, page-439
-
- There are more pages in this discussion • 632 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.040(3.16%) |
Mkt cap ! $1.490B | |||
| Open | High | Low | Value | Volume |
| $1.28 | $1.32 | $1.26 | $3.433M | 2.652M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39558 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 21776 | 3 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |